Skip to main content

Amgen United States revenue

  • AMGN · Nasdaq
  • Biotechnology
  • S&P 500
$465.67−0.30%Close 13 Nov 2026 · Market value $253.3B

United States revenue at Amgen came to $26.4B for the fiscal year to 31 Dec 2025, up 10.7% from a year earlier.

As Amgen reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 13 Feb 2026.

By fiscal year

$15.4BDec 2014$17.2BDec 2015$18.3BDec 2016$18.0BDec 2017$18.4BDec 2018$17.2BDec 2019$18.5BDec 2020$18.2BDec 2021$18.6BDec 2022$19.8BDec 2023$23.9BDec 2024$26.4BDec 2025
Amgen United States revenue, every reported period
Period endingUnited States revenueChange on a yearFiled
31 Dec 2025$26.4Bup 10.7%13 Feb 2026
31 Dec 2024$23.9Bup 20.5%14 Feb 2025
31 Dec 2023$19.8Bup 6.5%14 Feb 2024
31 Dec 2022$18.6Bup 2.2%9 Feb 2023
31 Dec 2021$18.2Bdown 1.6%16 Feb 2022
31 Dec 2020$18.5Bup 7.4%9 Feb 2021
31 Dec 2019$17.2Bdown 6.2%12 Feb 2020
31 Dec 2018$18.4Bup 1.8%13 Feb 2019
31 Dec 2017$18.0Bdown 1.6%13 Feb 2018
31 Dec 2016$18.3Bup 6.8%14 Feb 2017
31 Dec 2015$17.2Bup 11.5%16 Feb 2016
31 Dec 2014$15.4Bup 6.3%19 Feb 2015
31 Dec 2013$14.5Bup 7.9%24 Feb 2014
31 Dec 2012$13.4Bup 11.9%27 Feb 2013
31 Dec 2011$12.0B—29 Feb 2012

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Amgen: Product sales · Repatha revenue · EVENITY revenue · Prolia revenue · ENBREL revenue · TEZSPIRE revenue · TEPEZZA revenue · BLINCYTO revenue · Otezla revenue · Nplate revenue · UPLIZNA revenue · KRYSTEXXA revenue · IMDELLTRA/IMDYLLTRA revenue · Vectibix revenue · KYPROLIS revenue · Aranesp revenue · XGEVA revenue · ROW revenue · financial statements

Every KPI and segment of AMGN, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.